申请人:ABIVAX
公开号:US20170204063A1
公开(公告)日:2017-07-20
The present invention relates to a compound of formula (I) wherein: Formula (II) means an aromatic ring wherein V is C or N and when V is N; Q is N or O, provided that R″ does not exist when Q is O; R′ independently represent a hydrogen atom or a group chosen among a (C
1
-C
3
)alkyl group, a halogen atom, a hydroxy! group, a —COOR
1
group, a —NO2 group, a —NR
1
R
2
group, a morpholinyl or a morpholino group, a N-methylpiperazinyl group, a (C
1
-C3)fluoroalkyl group, a —O—P(=O)—(OR
3
XOR
4
) group, a (C
1
-C
4
)alkoxy group and a —CN group, and can further be a group chosen among: (IIa), (IIIa) or anyone of its pharmaceutically acceptable salt, for use in the treatment and/or prevention of an inflammatory disease.
本发明涉及一种化合物,其化学式为(I),其中:化学式(II)表示芳香环,其中V为C或N,当V为N时,Q为N或O,但当Q为O时,R″不存在;R′独立表示氢原子或从(C1-C3)烷基,卤素原子,羟基,—COOR1基团,—NO2基团,—NR1R2基团,吗啉基或吗啉基团,N-甲基哌嗪基团,(C1-C3)氟代烷基,—O—P(=O)—(OR3XOR4)基团,(C1-C4)烷氧基和—CN基团中选择的一种基团,并且还可以是选择于(IIa),(IIIa)或其任何药学上可接受的盐,用于治疗和/或预防炎症性疾病。